Detailed explanation of cabozantinib’s indications and purchasing channels

Cabozantinib (Cabozantinib) is an innovative multi-target tyrosine kinase inhibitor that is widely used to treat a variety of advanced cancers, especially in patients who have failed other treatment options. It inhibits tumor spread and proliferation by inhibiting multiple targets related to tumor growth, angiogenesis and metastasis, including MET, VEGFR and AXL. Therefore, cabozantinib is widely used to treat several different types of cancer and has shown clear clinical advantages during treatment.

Caboozantinib is primarily used to treat advanced renal cell carcinoma (RCC), especially in patients who have failed to respond to standard treatments, such as anti-angiogenic therapies. This type of cancer often develops rapidly and has a complicated course. Cabozantinib can effectively delay disease progression through targeted therapy. Second, it is also approved to treat advanced hepatocellular carcinoma (HCC), specifically in patients whose disease worsens after treatment with sorafenib, another commonly used drug. In addition, cabozantinib has also shown good efficacy in the treatment of medullary thyroid cancer (MTC), especially in patients with progressive disease and those who have received other therapies.

In addition to the above-mentioned main indications, cabozantinib is also being explored in some clinical trials for the treatment of other types of cancer, such as non-small cell lung cancer (NSCLC). However, its main applications are still concentrated in areas such as renal cell carcinoma, hepatocellular carcinoma and thyroid cancer. As clinical research advances, cabozantinib may be further validated for the treatment of more types of tumors in the future.

For patients who need to purchase cabozantinib, it can usually be purchased through hospital pharmacies, professional drug delivery platforms, and some online drug suppliers. Cabozantinib is a prescription drug and must be prescribed by a professional doctor before it can be purchased. Cancer treatment centers in major hospitals usually have a supply of cabozantinib. Patients can communicate with their attending doctors to find out whether this drug is suitable for use and how to purchase it.

Reference:https://en.wikipedia.org/wiki/Cabozantinib